Question: "What did Frederick want to leave Saxony?"  Context: "The Treaty of Hubertusburg, between Austria, Prussia, and Saxony, was signed on February 15, 1763, at a hunting lodge between Dresden and Leipzig. Negotiations had started there on December 31, 1762. Frederick, who had considered ceding East Prussia to Russia if Peter III helped him secure Saxony, finally insisted on excluding Russia (in fact, no longer a belligerent) from the negotiations. At the same time, he refused to evacuate Saxony until its elector had renounced any claim to reparation. The Austrians wanted at least to retain Glatz, which they had in fact reconquered, but Frederick would not allow it. The treaty simply restored the status quo of 1748, with Silesia and Glatz reverting to Frederick and Saxony to its own elector. The only concession that Prussia made to Austria was to consent to the election of Archduke Joseph as Holy Roman emperor."  Answer:
----
Answer: elector had renounced any claim to reparation


Question: "What was an early concern of his?"  Context: "In September 2003, retired four-star general Wesley Clark announced his intention to run in the presidential primary election for the Democratic Party nomination. His campaign focused on themes of leadership and patriotism; early campaign ads relied heavily on biography. His late start left him with relatively few detailed policy proposals. This weakness was apparent in his first few debates, although he soon presented a range of position papers, including a major tax-relief plan. Nevertheless, the Democrats did not flock to support his campaign."  Answer:
----
Answer: weakness was apparent in his first few debates


Question: "What is the final step?"  Context: "In the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective. This process generally involves submission of an Investigational New Drug filing with sufficient pre-clinical data to support proceeding with human trials. Following IND approval, three phases of progressively larger human clinical trials may be conducted. Phase I generally studies toxicity using healthy volunteers. Phase II can include pharmacokinetics and dosing in patients, and Phase III is a very large study of efficacy in the intended patient population. Following the successful completion of phase III testing, a New Drug Application is submitted to the FDA. The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted."  Answer:
----
Answer:
The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted